Kintor Pharmaceutical Ltd (9939.HK)
Company Info
| ISIN | KYG5273B1077 |
|---|---|
| Sector | Healthcare |
| Industry | Biotechnology |
Highlights
| Market Cap | HK$1.72B |
|---|---|
| EPS | HK$0.00 |
| PE Ratio | N/A |
| PEG Ratio | N/A |
| Revenue (TTM) | HK$34.23M |
| Gross Profit (TTM) | HK$34.23M |
| EBITDA (TTM) | -HK$956.45M |
| Year Range | HK$3.80 - HK$24.15 |
| Target Price | HK$12.50 |
Share Price Chart
Loading data...
Performance
The chart shows the growth of an initial investment of HK$10,000 in Kintor Pharmaceutical Ltd, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Compare to other instruments
Return
Kintor Pharmaceutical Ltd had a return of -59.90% year-to-date (YTD) and -82.75% in the last 12 months. Over the past 10 years, Kintor Pharmaceutical Ltd had an annualized return of -43.58%, while the S&P 500 had an annualized return of 11.23%, indicating that Kintor Pharmaceutical Ltd did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| 1 month | -23.00% | 3.19% |
| Year-To-Date | -59.90% | 9.50% |
| 6 months | -69.19% | 4.00% |
| 1 year | -82.75% | -2.77% |
| 5 years (annualized) | -43.58% | 11.23% |
| 10 years (annualized) | -43.58% | 11.23% |
Monthly Returns Heatmap
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 | 5.79% | -7.10% | -33.37% | -16.12% | -29.02% | |||||||
| 2022 | 6.91% | -25.94% |
Risk-Adjusted Performance
This table presents a comparison of risk-adjusted performance metrics for Kintor Pharmaceutical Ltd (9939.HK) and S&P 500 (^GSPC). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| Sharpe ratio | Sortino ratio | Omega ratio | Calmar ratio | Ulcer Index | |
|---|---|---|---|---|---|
9939.HK Kintor Pharmaceutical Ltd | -0.98 | ||||
^GSPC S&P 500 | 0.21 |
Dividend History
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below shows the maximum drawdowns of the Kintor Pharmaceutical Ltd. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Kintor Pharmaceutical Ltd is 95.48%, recorded on May 31, 2023. The portfolio has not recovered from it yet.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -95.48% | Sep 2, 2021 | 427 | May 31, 2023 | — | — | — |
| -66.33% | May 25, 2020 | 123 | Nov 19, 2020 | 79 | Mar 16, 2021 | 202 |
| -34.6% | May 24, 2021 | 18 | Jun 17, 2021 | 23 | Jul 21, 2021 | 41 |
| -24.9% | Mar 23, 2021 | 3 | Mar 25, 2021 | 13 | Apr 16, 2021 | 16 |
| -22.89% | Jul 22, 2021 | 4 | Jul 27, 2021 | 26 | Sep 1, 2021 | 30 |
Volatility Chart
The current Kintor Pharmaceutical Ltd volatility is 26.94%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.